1.
Silva AF da, Marques FRV, Freitas JC, Rivera JGB. PHARMACOTHERAPEUTIC FOLLOW-UP OF PATIENTS WHO USE TENOFOVIR DISOPROXIL FUMARATE IN PRE-EXPOSURE TO HIV. REASE [Internet]. 2023 Aug. 4 [cited 2024 May 19];9(7):351-63. Available from: https://periodicorease.pro.br/rease/article/view/10589